Patents
Allen & Overy’s top tier patent litigation team acts for the world’s leading companies in the most complex patent disputes.
A&O acts in multi-jurisdictional and national patent disputes across a range of sectors, particularly specialising in life sciences and technology. We represent clients in the many different courts and tribunals worldwide, leveraging the full range of dispute resolution methods to deliver commercial outcomes for clients.
We advise on the most significant and complex cases, including advising on some of the first disputes examining Standard Essential Patents and FRAND terms. We have also advised on cases involving Supplementary Protection Certificates and Second Medical Use.
A firm technical understanding is crucial to success. Many of our team members have technical backgrounds and industry experience and can advise with confidence in cases involving the most complex technologies.
Explore our services
Meet our lawyers
Our experience
Eli Lilly
in the defence of its patent on Cialis for the treatment of erectile dysfunction.
Samsung
in its French litigation adverse to Technicolor’s licensing arm on patents concerning 4G, video coding, and various smartphone features.
A multinational pharmaceutical company
in the complex enforcement of a patent relating to a valuable medicinal product. The patent covers the second medical use of a known active substance and the proper interpretation of patent claims is crucial to managing this litigation in Poland.
News and insights
Blog Post: 20 June 2022
Breaking: Global COVID-19 IPR waiver approved
Last Friday 17 June 2022, the WTO member states came to an agreement on the long negotiated TRIPS Waiver. In its annual 6 days conference (the Ministerial Conference), the WTO member states agreed…
News: 17 June 2022
Allen & Overy Lawyers named 2022 Managing Intellectual Property IP Stars
Managing Intellectual Property’s (Managing IP) has selected 19 Allen & Overy lawyers for its IP Stars (2022) guide. The publication is the leading specialist guide to IP law firms and practitioners…
Publications: 10 June 2022
The selection of a patent for Patent Term Extension (PTE) or Supplementary Protection Certification (SPC) exclusivities is a critical decision for new drug products.
Blog Post: 03 May 2022
Potential compromise on COVID-19 IPR waiver: deadlock resolved?
Last month, a leaked document regarding the TRIPS Waiver revealed a breakthrough between the EU, South Africa, India and the United States. After 18 months of negotiations, the four parties now have…
Awards and accolades
- Winner: IP Firm of the Year: Biologics/Biosimilars and IP Firm of the Year: Biotech, LMG European Life Sciences Awards 2020
- Winner: European Patent Litigation Firm of the Year, MIP EMEA Awards 2019
Recognition of our work
'It was a stellar team performance and we benefited from the pure value contributed,' a source reports, adding: 'There were no inefficiencies, it was seamless.
Chambers 2020 Life Sciences: IP/Patent Litigation
Allen & Overy remains a bellwether on the UK patent litigation market. Its all-star group ‘benefits from exceptional support provided by the wide full-service international firm’, and has been going from strength to strength of late.
IAM Patent 1000 2020
Related content
Intellectual property brochure
Digital maturity
A&O Digital Hub